Biomaterial‐Facilitated Local Delivery of Stem Cell‐Derived Small Extracellular Vesicles: Perspectives in Surgical Therapy

Author:

Tan Fei1234ORCID,Xu Maoxiang12,Li Xuran12,Wang Zhao1,Li Jiaojiao12,Shahzad Khawar Ali12

Affiliation:

1. Department of ORL‐HNS Shanghai Fourth People's Hospital and School of Medicine Tongji University Shanghai 200092 China

2. Plasma Medicine and Surgical Implants Center School of Medicine Tongji University Shanghai 200070 China

3. The Royal College of Surgeons in Ireland Dublin D02 YN77 Ireland

4. The Royal College of Surgeons of England London WC2A 3PP UK

Abstract

AbstractStem cell‐derived small extracellular vesicles (sEVs) have shown tremendous potential in regenerative medicine in recent years. These sEVs exert multiple therapeutic effects comparable or superior to their parental stem cells while avoiding the limitations of stem cell‐based therapy. The two routine modalities of sEV administration are systemic injection and local delivery. Various biomaterials are developed to assist their local delivery to improve the targeting of organs, minimize nonspecific accumulation in vital organs, and ensure the protection and release of sEVs. This comprehensive, up‐to‐date, specialty‐specific, disease‐oriented, and preclinical review is presented to expound on the surgical application and potential of stem cell‐derived sEVs. The local delivery of stem cell‐derived sEVscan treat numerous diseases encountered in orthopedic surgery, neurosurgery, plastic surgery, cardiothoracic surgery, general surgery, urology, otorhinolaryngology, ophthalmology, obstetrics and gynecology, and dental surgery. In addition, the biomaterials utilized encompass a wide range of sources (e.g., natural, synthetic, and hybrid polymers), format (e.g., scaffold, patch, spray, microneedle), and responsiveness (e.g., temperature, pH, and protein), which enables customized sEV therapy tailored to specific diseases. This review demonstrates biomaterial‐facilitated local delivery of stem cell‐derived sEVs as a viable alternative or even a superior option to systemic sEV therapy.

Funder

Fundamental Research Funds for the Central Universities

National Natural Science Foundation of China

Publisher

Wiley

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3